Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1992 May;47(5):355–359. doi: 10.1136/thx.47.5.355

Assessment of bronchodilatation after spontaneous recovery from a histamine challenge in asthmatic children.

P J Merkus 1, H M Rooda 1, E E van Essen-Zandvliet 1, E J Duiverman 1, P H Quanjer 1, K F Kerrebijn 1
PMCID: PMC463750  PMID: 1609378

Abstract

BACKGROUND: It would be convenient to be able to measure airway responsiveness to histamine and to bronchodilator drugs on the same day, but whether this can be done reliably is unknown. METHODS: The effect of a prior histamine challenge on the bronchodilator response to salbutamol after spontaneous recovery of FEV1 to 95% of the prechallenge level was studied in two groups of asthmatic children. Fourteen children inhaled 400 micrograms salbutamol after spontaneous recovery from a histamine challenge, followed by a further 100 micrograms salbutamol 20 minutes later. In a second group of eight asthmatic children the study was repeated with 800 micrograms salbutamol, followed by a further 200 micrograms 20 minutes later. RESULTS: After histamine challenge FEV1 returned to baseline in 70 minutes or less on all occasions. The FEV1 20 minutes after 400 micrograms salbutamol was significantly lower after the histamine challenge than on the control day. After the further 100 micrograms salbutamol FEV1 values were similar after the histamine challenge and on the control day. FEV1 values after 800 micrograms salbutamol and the further 200 micrograms dose were not influenced by a prior histamine challenge. CONCLUSIONS: In children with stable asthma in whom FEV1 has returned to baseline after a histamine challenge the FEV1 achieved after 800 micrograms salbutamol is not affected by the histamine challenge. Histamine and bronchodilator responsiveness can thus be assessed reliably on the same day in patients with stable asthma. This has clear advantages for patient care.

Full text

PDF
355

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J. Neural control of human airways in health and disease. Am Rev Respir Dis. 1986 Dec;134(6):1289–1314. doi: 10.1164/arrd.1986.134.5.1289. [DOI] [PubMed] [Google Scholar]
  2. Blackwell G. J., Flower R. J., Nijkamp F. P., Vane J. R. Phospholipase A2 activity of guinea-pig isolated perfused lungs: stimulation, and inhibition by anti-inflammatory steroids. Br J Pharmacol. 1978 Jan;62(1):79–89. doi: 10.1111/j.1476-5381.1978.tb07009.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boschetto P., Roberts N. M., Rogers D. F., Barnes P. J. Effect of antiasthma drugs on microvascular leakage in guinea pig airways. Am Rev Respir Dis. 1989 Feb;139(2):416–421. doi: 10.1164/ajrccm/139.2.416. [DOI] [PubMed] [Google Scholar]
  4. Brown J. K., Leff A. R., Frey M. J., Reed B. R., Lazarus S. C., Shields R., Gold W. M. Characterization of tracheal mast cell reactions in vivo. Inhibition by a beta-adrenergic agonist. Am Rev Respir Dis. 1982 Nov;126(5):842–848. doi: 10.1164/arrd.1982.126.5.842. [DOI] [PubMed] [Google Scholar]
  5. Cartier A., Malo J. L., Bégin P., Sestier M., Martin R. R. Time course of the bronchoconstriction induced by inhaled histamine and methacholine. J Appl Physiol Respir Environ Exerc Physiol. 1983 Mar;54(3):821–826. doi: 10.1152/jappl.1983.54.3.821. [DOI] [PubMed] [Google Scholar]
  6. Cockcroft D. W., Killian D. N., Mellon J. J., Hargreave F. E. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977 May;7(3):235–243. doi: 10.1111/j.1365-2222.1977.tb01448.x. [DOI] [PubMed] [Google Scholar]
  7. Connolly M. J., Stenton S. C., Avery A. J., Walters E. H., Hendrick D. J. Refractory period following bronchoconstriction provoked by histamine in asthmatic subjects. Thorax. 1989 Feb;44(2):146–150. doi: 10.1136/thx.44.2.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Deffebach M. E., Charan N. B., Lakshminarayan S., Butler J. The bronchial circulation. Small, but a vital attribute of the lung. Am Rev Respir Dis. 1987 Feb;135(2):463–481. doi: 10.1164/arrd.1987.135.2.463. [DOI] [PubMed] [Google Scholar]
  9. Gerritsen J., Koëter G. H., Akkerboom H. J., Knol K. Recovery of FEV1 after histamine challenge in asthmatic children. Clin Allergy. 1987 Mar;17(2):119–126. doi: 10.1111/j.1365-2222.1987.tb02329.x. [DOI] [PubMed] [Google Scholar]
  10. Heimer D., Shim C., Williams M. H., Jr The effect of sequential inhalations of metaproterenol aerosol in asthma. J Allergy Clin Immunol. 1980 Jul;66(1):75–77. doi: 10.1016/0091-6749(80)90141-4. [DOI] [PubMed] [Google Scholar]
  11. Long W. M., Sprung C. L., el Fawal H., Yerger L. D., Eyre P., Abraham W. M., Wanner A. Effects of histamine on bronchial artery blood flow and bronchomotor tone. J Appl Physiol (1985) 1985 Jul;59(1):254–261. doi: 10.1152/jappl.1985.59.1.254. [DOI] [PubMed] [Google Scholar]
  12. Malo J. L., Gauthier R., Lemire I., Cartier A., Ghezzo H., Martin R. R. Kinetics of the recovery of airway response caused by inhaled histamine. Am Rev Respir Dis. 1985 Oct;132(4):848–852. doi: 10.1164/arrd.1985.132.4.848. [DOI] [PubMed] [Google Scholar]
  13. Manning P. J., Jones G. L., O'Byrne P. M. Tachyphylaxis to inhaled histamine in asthmatic subjects. J Appl Physiol (1985) 1987 Oct;63(4):1572–1577. doi: 10.1152/jappl.1987.63.4.1572. [DOI] [PubMed] [Google Scholar]
  14. Mathé A. A., Hedqvist P., Holmgren A., Svanborg N. Bronchial hyperreactivity to prostaglandin F 2 and histamine in patients with asthma. Br Med J. 1973 Jan 27;1(5847):193–196. doi: 10.1136/bmj.1.5847.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Neijens H. J., Hofkamp M., Degenhart H. J., Kerrebijn K. F. Bronchial responsiveness as a function of inhaled histamine and the methods of measurement. Bull Eur Physiopathol Respir. 1982 May-Jun;18(3):427–438. [PubMed] [Google Scholar]
  16. Nieminen M. M., Holli H., Lahdensuo A., Muittari A., Karvonen J. Aerosol deposition in automatic dosimeter nebulization. Eur J Respir Dis. 1987 Sep;71(3):145–152. [PubMed] [Google Scholar]
  17. Persson C. G., Erjefält I., Grega G. J., Svensjö E. The role of beta-receptor agonists in the inhibition of pulmonary edema. Ann N Y Acad Sci. 1982;384:544–557. doi: 10.1111/j.1749-6632.1982.tb21399.x. [DOI] [PubMed] [Google Scholar]
  18. Pietra G. G., Szidon J. P., Leventhal M. M., Fishman A. P. Histamine and interstitial pulmonary edema in the dog. Circ Res. 1971 Oct;29(4):323–337. doi: 10.1161/01.res.29.4.323. [DOI] [PubMed] [Google Scholar]
  19. Platshon L. F., Kaliner M. The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation. J Clin Invest. 1978 Dec;62(6):1113–1121. doi: 10.1172/JCI109230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sleigh M. A., Blake J. R., Liron N. The propulsion of mucus by cilia. Am Rev Respir Dis. 1988 Mar;137(3):726–741. doi: 10.1164/ajrccm/137.3.726. [DOI] [PubMed] [Google Scholar]
  21. Steel L., Platshon L., Kaliner M. Prostaglandin generation by human and guinea pig lung tissue: comparison of parenchymal and airway responses. J Allergy Clin Immunol. 1979 Oct;64(4):287–293. doi: 10.1016/0091-6749(79)90146-5. [DOI] [PubMed] [Google Scholar]
  22. Vathenen A. S., Britton J. R., Ebden P., Cookson J. B., Wharrad H. J., Tattersfield A. E. High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis. 1988 Oct;138(4):850–855. doi: 10.1164/ajrccm/138.4.850. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES